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Paralog of XRCC4 and XLF (PAXX) is amember of the
XRCC4 superfamily and plays a role in nonhomolo-
gous end-joining (NHEJ), a DNA repair pathway crit-
ical for lymphocyte antigen receptor gene assembly.
Here, we find that the functions of PAXX and XLF in
V(D)J recombination are masked by redundant
joining activities. Thus, combined PAXX and XLF
deficiency leads to an inability to join RAG-cleaved
DNA ends. Additionally, we demonstrate that PAXX
function in V(D)J recombination depends on its inter-
action with Ku. Importantly, we show that, unlike
XLF, the role of PAXX during the repair of DNA breaks
does not overlap with ATM and the RAG complex.
Our findings illuminate the role of PAXX in V(D)J
recombination and support a model in which PAXX
and XLF function during NHEJ repair of DNA breaks,
whereas XLF, the RAG complex, and the ATM-
dependent DNA damage response promote end
joining by stabilizing DNA ends.INTRODUCTION
V(D)J recombination assembles immunoglobulin and T cell re-
ceptor variable exons from variable (V), diversity (D), and joining
(J) gene segments via a cut-and-paste mechanism (Bassing
et al., 2002). This process occurs in developing lymphocytes
during the G1 phase of the cell cycle and is initiated when the
recombination-activating gene products RAG1 and RAG2 (form-
ing the RAG endonuclease) introduce double-strand breaks
(DSBs) among V, D, and J coding gene segments and flanking
recombination signal sequences (RSSs) (Schatz and Swanson,
2011). RAG-mediated cleavage at a pair of RSSs generatesCell Repo
This is an open access article undfour broken DNA ends: two blunt 50 phosphorylated signal
ends (SEs) that terminate in the RSS and two covalently sealed
(hairpin) coding ends (CEs). After cleavage, the RAG proteins
stay associated with the DNA ends in a post-cleavage complex
(PCC) that is thought to contribute to end-stabilization and end-
joining activities (Deriano and Roth, 2013; Schatz and Swanson,
2011). Subsequently, the classical nonhomologous end-joining
(NHEJ) pathway joins these DNA ends in a recombinant con-
figuration, forming a coding joint (CJ) (the rearranged antigen
receptor gene) and a reciprocal signal joint (SJ) (Deriano and
Roth, 2013; Helmink and Sleckman, 2012; Schatz and Swanson,
2011). Additionally, RAG-induced DNA breaks activate the
ataxia telangiectasia mutated (ATM)-kinase-dependent DNA
damage response (DDR) (Helmink and Sleckman, 2012). ATM,
beyond activating p53-dependent G1/S checkpoints, contrib-
utes to the repair of chromosomal DSBs by stabilizing coding
ends in post-cleavage repair complexes most likely through
the activation of downstream targets (Bredemeyer et al., 2006).
Thus, the stabilization and tethering of broken DNA ends
depends on ATM kinase activity and the formation of
ATM-dependent DNA repair foci (Helmink and Sleckman,
2012; Kumar et al., 2014).
During NHEJ, the Ku70/80 heterodimer (Ku) binds DNA ends
and recruits the DNA-dependent protein kinase catalytic subunit
(DNA-PKcs) in order to form the DNA-PK holoenzyme (Gottlieb
and Jackson, 1993). DNA-PK phosphorylates multiple sub-
strates, promoting synapsis of DNA ends and facilitating the
recruitment of end processing and ligation enzymes. Finally,
the XRCC4-Ligase 4 complex performs ligation of DNA ends
(Deriano and Roth, 2013; Lieber, 2010). Deficiency for these
core NHEJ factors results in severe combined immunodeficiency
due to the inability to complete repair of RAG DNA breaks (Blunt
et al., 1995; Deriano and Roth, 2013; Helmink and Sleckman,
2012; Revy et al., 2005; Rooney et al., 2004), thus highlighting
the importance of identifying all players in this process and
deciphering their functions.rts 16, 2967–2979, September 13, 2016 ª 2016 The Authors. 2967
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
XRCC4 and the XRCC4-like factor (XLF) are two members of
the same protein family and share structural similarity (Andres
et al., 2007; Callebaut et al., 2006; Li et al., 2008b). XLF stimulates
the XRCC4/Ligase 4 complex through an uncertain mechanism,
and together, XLF and XRCC4 form long filaments thought to
help DNA end tethering during NHEJ (Hammel et al., 2011; Ma-
haney et al., 2013; Reid et al., 2015; Riballo et al., 2009; Ropars
et al., 2011; Roy et al., 2015; Tsai et al., 2007). In contrast to other
NHEJ factor deficiencies, XLF-deficient mice are not markedly
immune-deficient, and pro-B cell lines derived from these ani-
mals perform nearly normal V(D)J recombination (Lescale and
Deriano, 2016; Li et al., 2008a; Vera et al., 2013). This apparently
nonessential role is at least partly due to functional redundancy
between XLF and members of the ATM DDR (Kumar et al.,
2014; Zha et al., 2011). Additionally, we recently demonstrated
that XLF function in the repair of RAGDNA breaks is alsomasked
by redundancy with RAG2 (Lescale et al., 2016). Consistent with
this, induction of RAG-mediated recombination in pro-B cell lines
deficient for XLF and ATM or expressing a C-terminal truncated
form of RAG2 in the absence of XLF similarly leads to a block in
V(D)J recombination and severe immune-deficiency due to an
inability to repair DSB intermediates (Kumar et al., 2014; Lescale
et al., 2016; Zha et al., 2011).
PAXX, a paralog of XRCC4 and XLF (Ochi et al., 2015), is a
recently identified component of the NHEJ machinery (Craxton
et al., 2015; Ochi et al., 2015; Xing et al., 2015). It has been shown
to accumulate at sites of DNA damage and function with XRCC4
and XLF to mediate DSB repair and cell survival in response to
DSB-inducing agents. PAXX itself does not bind DNA but inter-
acts with Ku and Ku-bound DNA in order to promote NHEJ factor
assembly and enhance DNA end ligation (Ochi et al., 2015; Roy
et al., 2015; Xing et al., 2015). In addition, episomal recombina-
tion assays performed in HEK293 cells showed that loss of
PAXX accentuates the requirement for XLF in joining coding
and signal ends (Roy et al., 2015), indicating that PAXX might
play important functions during antigen receptor gene assembly
in lymphocytes. Here, we used a physiological RAG-inducible B
cell line system to investigate the role of PAXX during V(D)J
recombination and uncover potential functional interactions
with XLF, the ATM-dependent DDR and the RAG complex during
repair of RAG-generated DSB intermediates.
RESULTS
Generation of PAXX-Deficient v-abl pro-B Cells using
CRISPR/Cas9 Gene Editing
We employed CRISPR/Cas9-mediated gene editing to delete
Paxx (Dexons1–4) from wild-type (WT) v-Abelson (v-abl) immor-
talized pro-B cells (Lescale et al., 2016), generatingPaxx/ v-abl
pro-B cell clones (Figures 1A and S1A; Table S1). Paxx-deleted
clones were selected on the basis of PCR analysis (Figures 1B
and S1B) and complete loss of PAXX protein expression (Figures
1C and S1C). In addition, we generated Xlf/ and Paxx/ Xlf/
v-abl pro-B cell clones by deleting Xlf (Dexon1) from wild-type
and Paxx/ cells (Figure S1A; Table S1; data not shown),
respectively. We also generated Xrcc4/ clones by deleting
exon3 of Xrcc4, which encodes part of the XRCC4 functional
core region (Gao et al., 1998; Mizuta et al., 1997), from wild-2968 Cell Reports 16, 2967–2979, September 13, 2016type v-abl pro-B cells (Figure S1A; Table S1; data not shown).
To test whether PAXX-deficient v-abl pro-B cells harbor defects
in NHEJ-mediated DSB repair, we performed survival assays af-
ter exposing the cells to ionizing radiation.We found thatPaxx/
v-abl pro-B cell clones were significantly more radiosensitive
than wild-type v-abl pro-B cell lines but less sensitive than
XLF- and XRCC4-deficient v-abl pro-B cells (Figure 1D; Table
S2). Strikingly, the loss of both PAXX and XLF in Paxx/ Xlf/
pro-B cells led to extreme radiosensitivity in comparison to
WT, PAXX, XLF, and XRCC4 single-mutant cells. Thus, we find
that PAXX and XLF are not epistatic for the repair of irradia-
tion-induced DNA damage in mouse v-abl pro-B cells.
Igk Rearrangement in PAXX- and PAXX/XLF-Deficient
pro-B Cells
Treatment of v-abl immortalized pro-B cells with a v-abl kinase
inhibitor (STI571, hereafter referred to as ABLki) leads to G1
cell-cycle arrest, the rapid induction and stabilization of
RAG1/2 gene expression, and rearrangement of the endogenous
Igk locus or any introduced V(D)J recombination reporter sub-
strate (Bredemeyer et al., 2006; Lescale et al., 2016; Muljo and
Schlissel, 2003). To elucidate whether PAXX has a role in RAG-
mediated DSB repair in lymphocytes, we initially quantified the
presence of DNA-damage-associated protein (53BP1) foci at
the Igk locus in G1-arrested pro-B cells using automated 3D
microscopy (Lescale et al., 2016). As expected (Lescale et al.,
2016), upon treatment with ABLki for 3 days, we found that
31.1% of WT pro-B cells showed intense 53BP1 foci, the major-
ity of which contained a single distinct spot, although cells were
occasionally found to contain two, and less frequently three or
more, foci (Figures 2A and 2B; Table S3). In ABLki-treated
RAG2-deficient pro-B cells (Rag2/), 53BP1 foci were detected
in only 18.2% of the cells, consistent with the absence of RAG
cleavage in these cells (Lescale et al., 2016; Shinkai et al.,
1992). The few foci observed in the absence of RAG activity likely
result from incomplete DNA synthesis during S phase leading to
the DDR and formation of 53BP1 domains during subsequent G1
(Harrigan et al., 2011). Interestingly, 43% of PAXX-deficient
pro-B cells showed 53BP1 foci, slightly more than in WT pro-B
cells and comparable to XLF-deficient cells (46.6%). However,
strikingly, we found that 80.1% of Paxx/ Xlf/ pro-B cells
harbored 53BP1 foci similar to Ku80 (64.5%) and XRCC4
(73.5%) deficiency (Figures 2A and 2B; Table S3). Also re-
miniscent of Ku80- and XRCC4-deficient pro-B cells, 20.1% of
Paxx/ Xlf/ cells contained two 53BP1 foci corresponding
to DNA breaks at both Igk alleles (Lescale et al., 2016) in compar-
ison to 3.6%, 4.3%, 6.1%, and 7.3% in Rag2/, WT, Paxx/,
and Xlf/ pro-B cells, respectively (Figures 2A and 2B; Table
S3). These results indicate that RAG-mediated DNA breaks are
readily formed in PAXX- and PAXX/XLF-deficient cells, however,
and in contrast to single deficiency, repair of these DNA breaks
does not seem to occur in combined PAXX/XLF deficient cells,
paralleling what is seen in the absence of the canonical NHEJ
factors Ku80 and XRCC4.
Consistent with the accumulation of 53BP1 foci in Paxx/
Xlf/ pro-B cells, PCR amplification of inversional IgkV6-23-J1
rearrangement (Figure 2C) in these cells revealed an almost
complete lack of CJ formation, validating the presence of a
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Figure 1. CRISPR/Cas9-Mediated Deletion
of Paxx in v-abl pro-B Cells and Irradiation
Sensitivity
(A) CRISPR/Cas9 Paxx knockout strategy. Exons
are shown in boxes, and sgRNA positions are
indicated. See also Figure S1A.
(B) PCR analysis showing the deletion of approx-
imately 626 bp in the Paxx gene (WT = 1,299 bp
band; Paxx KO z673 bp band). See also Fig-
ure S1B.
(C) Western blot showing the absence of the PAXX
protein in Paxx-deleted pro B cell clones. See also
Figure S1C.
(D) Irradiation sensitivity of v-abl pro-B cell lines.
The graph represents mean ± SEM of three inde-
pendent experiments using two independent cell
lines (see also Table S2). Numbers indicate the
percentage of survival 3 days after irradiation at 1,
2.5, and 5 Gy. See also Table S2.specific end-joining defect in the absence of functional PAXX
and XLF during V(D)J recombination (Figure 2D). Induction of
RAG in WT, Xlf/, and Paxx/ pro-B cells triggered robust
Vk-to-Jk inversional CJ formation, whereas there was a com-
plete absence of IgkV6-23-J1 rearrangements after the induction
of RAG in Xrcc4/ pro-B cells due to the function of XRCC4 in
repairing RAG-DSBs (Li et al., 1995). Notably, nested PCR ampli-
fication of inversional IgkV6-23-J1 rearrangement also revealed
the formation of deletional hybrid joints (HJs), which resultsCell Reportsfrom the aberrant joining of a coding to
a signal end, in Atm/ and in Xlf/ cells,
consistent with a role for ATM and XLF in
stabilizing cleaved DNA ends and thus
suppressing HJs (Bredemeyer et al.,
2006; Lescale et al., 2016). In contrast,
analysis of IgkV6-23-J1 rearrangements in
PAXX-deficient pro-B cells did not reveal
HJs, suggesting that PAXX, unlike its pa-
ralog XLF, most likely has a very minor, if
any, role in stabilizing DNA ends within
post-cleavage complexes (Figure 2D,
see also below and Discussion).
Coding and Signal Joint Defects in
Paxx/ Xlf/ pro-B Cells
To unequivocally test for V(D)J recombi-
nation defects in PAXX/XLF-deficient
cells, we transduced v-abl pro-B cell lines
from each genotype with the pMX-RSS-
GFP/IRES-hCD4 retroviral recombination
substrate (pMX-INV) in which GFP is ex-
pressed upon successful chromosomal
inversional RAG-mediated recombina-
tion and allows for the assessment of
the rearrangement status and recombi-
nation intermediates by Southern blot
analysis (Figure 3A) (Bredemeyer et al.,
2006; Lescale et al., 2016). Both assaysconfirmed robust levels of rearrangements in ABLki-treated
WT, Xlf/, and Paxx/ cells (Figures 3B and 3C). Interestingly,
although both Paxx/ and Xlf/ pro-B cells are proficient at
recombining, we consistently found significantly higher levels
of rearrangements in Paxx/ pro-B cells than Xlf/ pro-B cells
(Figure 3B, 45% recombination in Paxx/ cells versus 26%
recombination in Xlf/ cells, p < 0.001, Figure 3C). These results
are reminiscent of the stronger radiation sensitivity observed in
XLF-deficient cells in comparison to PAXX-deficient cells16, 2967–2979, September 13, 2016 2969
Figure 2. Accumulation of 53BP1 DDR Foci and Impaired Igk Rearrangement in Paxx/ Xlf/ pro-B Cells
(A) Representative 3D projections of 53BP1 immunostaining conducted on ABLki-treated v-abl pro–B cells.
(B) Percentage of v-abl pro–B cells harboring 1, 2, or >2 53BP1 foci 65 hr post ABLki treatment. Data represent mean ± SEM from three independent experiments
with one or two independent cell lines for each genotype. See also Table S3.
(C) Schematic of the Igk locus with position of primers (arrows) used to assay coding joint (CJ) and hybrid joint (HJ) formation during inversional IgkV6-23-J1
rearrangement.
(D) Semiquantitative nested PCR analysis of IgkV6-23-J1 coding joints (CJ) and hybrid joints (HJ) from indicated v-abl pro-B cell lines treated for 72hwith ABLki. Il-2
gene PCR was used as a loading control.(Figure 1D) and suggest that XLF deficiency leads to a more
profound defect in repairing DSB than PAXX deficiency.
Strikingly, flow cytometry analysis revealed severely impaired
inversional rearrangement in Paxx/ Xlf/ cells in comparison
to WT (z115-fold decrease, p < 0.001), Paxx/ (z97-fold2970 Cell Reports 16, 2967–2979, September 13, 2016decrease, p < 0.001), and Xlf/ (z56-fold decrease, p <
0.001) cells (Figure 3B). Southern blot and PCR analysis
confirmed severe end-joining defects in Paxx/ Xlf/ cells, as
revealed by a marked decrease in CJs and a marked increase
in unjoined CEs, indicative of a classical NHEJ defect (Figures
Figure 3. Defective Inversional V(D)J Recombination in Paxx/ Xlf/ B Cells
(A) Schematic of pMX-INV recombination substrate. The 12 recombination signal sequence (RSS-12; black triangle), GFP cDNA, 23 recombination signal
sequence (RSS-23; gray triangle), internal ribosome entry site (IRES)-human CD4 cDNA (IRES-hCD4), long-terminal repeats (LTRs), EcoRV (EV) sites, NcoI (N)
site, C4 probe (pink bar), and the expected sizes for the un-rearranged substrate (UR), coding end intermediates (CE), CJs and HJs are indicated.
(B) v-abl pro–B cell lines treated for 72 hr with ABLki with or without ATMkinase inhibitor (ATMki) were assayed for pMX-INV rearrangement by flow cytometrywith
the percentage of GFP expressing cells indicated. Data represent mean ± SEM of at least four independent experiments using two WT (12095 and 12096), two
Paxx/ (P96B1 and P96B13), four Xlf/ (16218, 16488, X95-3, and X95-4), two Paxx/ Xlf/ (XP1 and XP6), and one Ku80/ (12071) independent cell lines. *,
0.01% p < 0.05; **, 0.001% p < 0.01; ***, p < 0.001.
(C) The indicated v-abl pro-B cell lines containing the pMX-INV substrate were treated for 72 hr with ABLki with or without ATMki and assayed by Southern blotting
with EcoRV/NcoI digest-C4 probe (top) and EcoRV digest-C4 probe (bottom). See also Figure S2.3C and S2). Notably, the intensity of the inversional V(D)J recom-
bination defect in Paxx/ Xlf/ cells was similar to that of Ku80-
and XRCC4-deficient cells (Figures 3B and 3C). Paxx/ Xlf/
cells treated with ABLki and the ATM-specific inhibitor
Ku55933 (ATMki) (Hickson et al., 2004) showed stronger levels
of unrepaired CEs in comparison to ABLki-treated Paxx/
Xlf/ cells, indicating that a fraction of unrepaired CEs are
subjected to ATM-dependent end degradation in PAXX/XLF-
deficient cells similar to what has been previously reported in
the context of Ku80, core RAG2/XLF, H2AX/XLF, and 53BP1/
XLF deficiency (Helmink et al., 2011; Lescale and Deriano,
2016; Zha et al., 2011).To identify specific defects in CJ and SJ formation, we gener-
ated multiple v-abl pro-B cell lines from each genotype that
harbored either a chromosomal deletional substrate designed
to assay CJs and unjoined CEs (pMX-DELCJ; Figure 4A) or a
chromosomal deletional substrate designed to assay SJs and
unjoined SEs (pMX-DELSJ; Figure 4B) (Bredemeyer et al.,
2006). In agreement with the aforementioned observations, in-
duction of RAG in WT, Xlf/, and Paxx/ cells generated
substantial CJ and SJ levels with no obvious free CEs and SEs
(Figures 4C, 4D, and S3). By contrast, Paxx/ Xlf/ cells had
very little accumulation ofCJs or SJs,whichwere only detectable
after PCRamplification, and, instead accumulated un-joinedCEsCell Reports 16, 2967–2979, September 13, 2016 2971
Figure 4. Defective Deletional V(D)J Recombination in Paxx/ Xlf/ B Cells
(A and B) Schematics of pMX-DELCJ (A) and pMX-DELSJ (B) recombination substrates with intermediates and products as defined for pMX-INV (Figure 3A).
(C and D) v-abl pro-B cell lines containing pMX-DELCJ (C) or pMX-DELSJ (D) were treated for 72 hr with ABLki with or without ATMki and assayed by Southern
blotting with EcoRV digest-C4 probe. See also Figures S3 and S4 and Table S4.and SEs (Figures 4C and 4D and S3). To determine the fidelity of
rare SJ formation in Paxx/ Xlf/ cells, we subjected SJ PCR
products to digestion with the restriction enzyme ApaLI, which
exclusively digests SJs formed without the loss or addition of nu-
cleotides (Bogue et al., 1998; Ramsden et al., 1997). Unlike SJs
formed in WT and PAXX-deficient pro-B cells, which are largely
ApaLI sensitive, SJs derived fromPAXX/XLF- andKu80-deficient
pro-B cells were almost exclusively resistant to ApaLI digestion,
indicating that the rare SJs formed in these cells were imperfect
(Figure S4A). SJs fromXLF-deficient pro-B cells were also imper-2972 Cell Reports 16, 2967–2979, September 13, 2016fect, although to a lesser extent than those observed in Paxx/
Xlf/ and Ku80/ cells (Figure S4). Consistently, sequencing
of SJs derived from Paxx/ Xlf/ and Ku80/ cells revealed
increaseddeletions and utilization ofmicro-homology in compar-
ison to WT, Paxx/, and Xlf/ cells (Figures S4B–S4D; Table
S4), demonstrating aberrant joining of signal ends by alternative
NHEJ (Deriano and Roth, 2013) in PAXX/XLF-deficient pro-B
cells. Taken together, these results provide strong evidence
that PAXX and XLF double deficiency leads to a severe NHEJ
defect in recombining lymphocytes.
Figure 5. Paxx/ Atm/ and Paxx/
Rag2c/c B Cells Perform Robust V(D)J
Recombination
(A) v-abl pro–B cell lines treated for 72 hr with
ABLki with or without ATM kinase inhibitor (ATMki)
were assayed for pMX-INV rearrangement by flow
cytometry with the percentage of GFP expressing
cells indicated. Data represent mean ± SEM of
at least four independent experiments with two
WT (12095 and 12096), two Paxx/ (P96B1 and
P96B13), two Rag2c/c (12018 and 12019), two
Paxx/Rag2c/c (P18B2 and P19B12), two Atm/
(160 and 13563), and one Paxx/ Atm/
(P563A23) independent cell lines. *, 0.01 % p <
0.05; **, 0.001% p < 0.01; ***, p < 0.001.
(B) PCR analysis of pMX-INV CJs and HJs from
indicated v-abl abl pro-B cell lines treated for 72 hr
with ABLki with or without ATMki. Il-2 gene PCR
was used as a loading control.PAXX Function in V(D)J Recombination Does Not
Overlap with ATM
Previous studies have shown that XLF functions in a cooperative
manner with several members of the ATM-dependent DSB
response pathway in joining DNA breaks during V(D)J recombi-
nation (Kumar et al., 2014; Zha et al., 2011). Because the ATM-
DSB response relies on the kinase activity of ATM, treatment
of XLF-deficient pro-B cells with an ATM-specific inhibitor
abrogates V(D)J recombination in these cells (Kumar et al.,
2014; Lescale et al., 2016; Zha et al., 2011). Based on the struc-
tural similarities that exist between XLF and PAXX (Ochi et al.,
2015; Xing et al., 2015), we envisioned that PAXX might also
be functionally redundant with the ATM-DSB response during
V(D)J recombination. To test this hypothesis, we treated
pMX-INV-transduced v-abl pro-B cell lines with ABLki and
ATMki (Figures 3 and S2). As expected (Lescale et al., 2016;
Zha et al., 2011), rearrangement was almost completely abol-
ished in Xlf/ pro-B cells treated with ATMki, leading to a strongCell Reportsdecrease in the percentage of GFP-posi-
tive pro-B cells (Figure 3B) and the accu-
mulation of CEs instead of CJ products
(Figure 3C). Inhibition of the ATM kinase
activity in WT led to robust recombination
(Figure 3B) and a specific accumulation
of CEs (Figures 3C, 4C, 4D, S2, and S3)
due to the role of ATM in stabilizing cod-
ing ends within post-cleavage complexes
(Bredemeyer et al., 2006; Helmink and
Sleckman, 2012). Strikingly, and in sharp
contrast to XLF deficiency, pMX-INV
rearrangement was not dramatically
affected in Paxx/ pro-B cells treated
with ATMki in comparison to untreated
Paxx/ pro-B cells and ATMki-treated
WT pro-B cells (Figures 3B, 3C, and S2).
Consistently, we also observed robust
CJ and SJ formation in pMX-DELCJ
Paxx/ pro-B cells and pMX-DELSJPaxx/ pro-B cells treated with ATMki, respectively (Figures
4C, 4D, and S3). Altogether, these results indicate that PAXX
does not rely on ATM kinase activity during V(D)J recombination.
To further substantiate that PAXX function in V(D)J recombina-
tion is not redundant with ATM, we also generated PAXX/ATM
doubly deficient pro-B cell lines by deleting Paxx from Atm/
pro-B cells (Figure S1; Table S1; data not shown). To quantify
V(D)J recombination efficiency, we chromosomally integrated
the pMX-INV substrate in pro-B cell clones (Figure 3A) and
triggered RAG expression. In contrast to Xlf/ Atm/ pro-B
cells (Zha et al., 2011) and Paxx/ Xlf/ pro-B cells (Figure 3B)
and in agreement with our ATMki results (Figures 3 and 4), PAXX/
ATM double knockout pro-B cells performed quite robust
inversional recombination in comparison to ATM single knockout
pro-B cells (Figures 5A and 5B). These results indicate that,
although XLF and PAXX paralogs functionally overlap in repairing
RAG-induced signal ends and coding ends, they diverge with
regard to their respective redundancy with ATM.16, 2967–2979, September 13, 2016 2973
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Figure 6. PAXX Function in the Absence of XLF Depends on Its Interaction with Ku
(A) Paxx/ Xlf/ v-abl pro–B cell lines (XP1, XP6) were transfected with expression vectors encoding for mRuby2, mRuby2-PAXXWT, or mRuby2-PAXXS184A.
After 6 hr recovery, Paxx/ Xl/ transfected cells, along with controls, were treated for 96 hr with ABLki and assayed for pMX-INV rearrangement by flow
cytometry with the percentage of GFP-expressing cells indicated. Data represent mean ± SEM of three independent experiments using two independent cell
lines for each genotype. See also Figure S6.
(B) PCR analysis of pMX-INV CJs and HJs from control and ABLki-treated Xlf/ and Paxx/ Xlf/ pro-B cell lines expressing mRuby2-PAXXWT or mRuby2-
PAXXS184A. Il-2 gene PCR was used as a loading control.PAXX Function in V(D)J Recombination Does Not
Overlap with the RAG2 C Terminus
We recently showed that XLF also cooperates with the RAG
complex in repairing DNA breaks. Thus, in the context of RAG2
lacking the C terminus domain (Rag2c/c mutant, also referred to
as core RAG2), XLF deficiency leads to a profound lymphopenia
associated with a severe defect in V(D)J recombination (Lescale
et al., 2016). These results led us to propose a model in which
the RAG proteins and the ATM-DSB response might participate
in a same pathway (i.e., allowing the stabilization of cleaved DNA
ends) that is functionally redundant with XLF (Lescale et al.,
2016). To test for potential functional interaction between the
RAG complex and PAXX, we deleted Paxx from core RAG2-
expressing v-abl pro-B cell lines (Lescale et al., 2016) (Figure S1;
Table S1). Induction of RAG in pMX-INV transduced Paxx/
Rag2c/c pro-B cells led to robust recombination in comparison to
core RAG2-expressing pro-B cells as measured by flow
cytometry and PCR analysis (Figures 5A and 5B). In addition,
pMX-INV rearrangement was not dramatically affected in Paxx/
Rag2c/c pro-B cells treated with the ATMki in comparison to un-
treated Paxx/ Rag2c/c pro-B cells and ATMki-treated Rag2c/c
pro-B cells (Figures 5A and 5B). Together, these results demon-
strate that, unlike XLF, PAXX does not functionally overlap with
theRAGcomplex in the repairofRAG-generatedDNAends.These
findings also indicate that, during V(D)J recombination, the redun-
dancy between XLF and PAXX is mechanistically distinct from the
previously reported redundancy between XLF and RAG/ATM-
DDR (Kumar et al., 2014; Lescale et al., 2016; Zha et al., 2011).
PAXX Function in the Absence of XLF Depends on Its
Interaction with Ku
We recently reported that PAXX function during the repair of
ionizing radiation-induced DNA damage depends on its ability2974 Cell Reports 16, 2967–2979, September 13, 2016to bind Ku (Ochi et al., 2015). PAXX-Ku interaction stimulates
DNA end ligation by Ligase 4, promotes assembly of core NHEJ
factors on damaged chromatin, and depends on the C terminus
of PAXX, specifically residues V199 and F201 (Ochi et al., 2015).
Here, we found that mutating the highly conserved residue
S184 to glutamate (PAXXS184E) similarly abolishes PAXX interac-
tion with Ku (Figure S5). To investigate whether the PAXX-Ku
interaction is required for V(D)J recombination in the context of
XLF deficiency, we expressed mRuby2 fluorescent protein
(mRuby2),mRuby2-taggedWTPAXXprotein (mRuby2-PAXXWT),
andmRuby2-PAXXS184E protein in pMX-INVPaxx/ Xlf/ pro-B
cells (Figure 6). Expression of mRuby2-PAXXWT, but not mRuby2
and mRuby2-PAXXS184E, substantially restored recombination in
RAG-induced Paxx/ Xlf/ pro-B cells (Figure 6A). In line with
this, complementationwith PAXXWT in Paxx/ Xlf/, pro-B cells
also led to the formation of CJs andHJs characteristic of XLF sin-
gle deficiency (Lescale et al., 2016) (Figure 6B). To strengthen
these results, we transfected Paxx/ Xlf/ pro-B cells carrying
a modified m-Cherry version of the pMX-INV recombination sub-
strate (Figure S6A) with expression vectors (Ochi et al., 2015) en-
coding for GFP, GFP-tagged PAXXWT, GFP-tagged C-terminally
truncated PAXX1–145, and GFP-tagged PAXXV199A/F201A. Ectopic
expression of GFP-PAXXWT, but not the Ku interaction-deficient
proteins GFP-PAXX1–145 and GFP-PAXXV199A/F201A, partially
restored RAG-mediated rearrangements in Paxx/ Xlf/ pro-B
cells (Figure S6B). Together, these data support a model in which
the PAXX-Ku interaction is crucial for PAXX function in V(D)J
recombination.
DISCUSSION
PAXX, XRCC4, and XLF comprise a homologous superfamily of
structurally related proteins that participate in the repair of DSBs
by NHEJ (Ochi et al., 2015; Ochi et al., 2014). Here, we show that
PAXX has a key role in V(D)J recombination that is masked by
functional redundancy with XLF. Our results support a model in
which the PAXX, XRCC4, and XLF paralogs play distinct redun-
dant and nonredundant functions in the repair of RAG-generated
DNA ends, specifically in the locking and joining steps, during
antigen receptor gene assembly (Figure 7).
Recent studies have shown that XLF is redundant with several
members of the ATM-DDR and the RAG complex in joining
broken DNA ends (Deriano and Roth, 2013; Helmink and Sleck-
man, 2012; Kumar et al., 2014; Lescale et al., 2016; Zha et al.,
2011). This redundancy is thought to rely, at least partially, on
the ability of these complexes to assemble a synaptic complex
that bridges DNA ends: the ATM-DDR through the formation of
chromatin-associated DNA repair foci, the RAG complex
through an unknown mechanism, and XLF via the formation of
XLF/XRCC4 DNA end-bridging filaments. In contrast to XLF,
we conclude that, based on several observations, PAXX does
not participate in stabilizing RAG-DNA breaks (Figure 7). We
reveal that Paxx/ Atm/ pro-B cells support robust V(D)J
recombination, demonstrating that, unlike XLF, PAXX does not
functionally overlap with ATM in repairing coding and signal
ends (Figures 3–5, S2, and S3). Notably, we observed a small
but significant decrease in overall recombination in Paxx/
Atm/ pro-B cells in comparison to Paxx/ pro-B cells and
Atm/ pro-B cells (Figure 5A). This decrease could be attributed
to additive NHEJ defects in the absence of PAXX and ATM (Crax-
ton et al., 2015; Kumar et al., 2014; Ochi et al., 2015; Xing et al.,
2015). We also found that, similar to PAXX/ATM deficiency,
PAXX-deficient pro-B cells expressing the core RAG2 mutant
protein (Paxx/ Rag2c/c) perform robust V(D)J recombination.
Additionally, treatment of Paxx/ Rag2c/c pro-B cells with a
specific ATM kinase inhibitor does not abrogate recombination
in these cells (Figure 5), indicating that, in the absence of a func-
tional RAG/ATM-DDR complex, PAXX is not required for synap-
sis and joining of DNA ends. In line with this, destabilization of the
post-cleavage synaptic complex in Atm/ and Xlf/ pro-B
cells irremediably leads to the formation of HJs (Bredemeyer
et al., 2006; Lescale et al., 2016); however, we did not detect
HJs in recombining PAXX-deficient pro-B cells (Figure 2). Lastly,
in line with previous results (Bredemeyer et al., 2006), we show
that ATM deficiency leads to the accumulation of coding ends
but not signal ends (Figure 4). This discrepancy is thought to
rely on the proclivity of the RAG to bind more avidly to signal
end pairs in comparison to coding end pairs (Agrawal and
Schatz, 1997; Bredemeyer et al., 2006; Helmink and Sleckman,
2012; Hiom and Gellert, 1998; Schatz and Swanson, 2011).
Combined ATM/XLF deficiency leads to an almost complete
lack of CJs associated with an accentuated accumulation of
coding ends and to the accumulation of signal ends, which is
consistent with a redundant role for XLF in stabilizing DNA
ends (Figure 4) (Zha et al., 2011). In sharp contrast, we find
that PAXX/ATM deficiency does not affect coding and signal
DSB intermediates beyond that of ATM single deficiency (Fig-
ures 4, 5, and S3). Altogether, our results strongly indicate that
PAXX does not play a major role in stabilizing and tethering
DNA ends during RAG-mediated rearrangements (Figure 7).
Interestingly, Roy et al., (2015) have also recently shown thatPAXX does not enhance the cellular requirement for XRCC4/
XLF interaction and potential DNA end bridging in human epithe-
lial cells.
We find that, upon RAG cleavage, more than 80% of Paxx/
Xlf/ pro-B cells accumulate 53BP1 DNA damage foci (Figures
2A and 2B). This is consistent with the accumulation of unre-
paired RAG-DNA ends in these cells and in the context of other
end-joining deficiency such as in XRCC4-, Ku80-, and core-
RAG2/XLF-deficient cells (Figures 2–4, S2, and S3) (Lescale
et al., 2016). Notably, a fraction of these 53BP1 foci might also
arise due to under-replicated DNA (Harrigan et al., 2011). This
possibility is in agreement with the observation that fibroblasts
derived from immune-deficient patients carrying XLF mutations
exhibit impaired cellular response to replication stress (Schwartz
et al., 2009). It will be interesting to investigate the specific roles
of XRCC4 paralogs and, more generally, components of the
NHEJ pathway, during replication and to determine to which
extent it contributes to the formation of 53BP1 foci in G1-ar-
rested cells. Nonetheless, the complete lack of rearrangement
and accumulation of unrepaired DNA ends observed in XLF/
PAXX-deficient pro-B cells is consistent with a severe end-
joining defect in these cells (Figures 2–4, S2, and S3). In line
with a role for PAXX in NHEJ-mediated repair, we find that
PAXX-Ku interaction is required for PAXX function in V(D)J
recombination in the absence of XLF (Figures 6 and S6). Addi-
tionally, sequencing of rare joints in Paxx/ Xlf/ pro-B cells
revealed increased end resection and micro-homology usage
reminiscent of joints found in the absence of core NHEJ factors
(Figure S4) (Deriano and Roth, 2013). Therefore, PAXX promotes
the joining of coding and signal ends during V(D)J recombination
(Figure 7).
The observation that Xlf/ cells are more radiosensitive than
Paxx/ cells (Figure 1D) is consistent with our findings that
PAXX and XLF have redundant (i.e., end-joining) and non-redun-
dant (i.e., end-stabilization) functions in the context of the repair
of RAG-generated DNA breaks. Thus, upon irradiation-induced
DSBs, XLF-deficient cells might suffer from defects in both
end-stabilization and end-joining whereas PAXX-deficient cells
only display defects in end-joining. The more severe radiosensi-
tivity observed in PAXX/XLF-deficient cells is congruent with a
complete lack of DNA end joining in these cells. More surprising
is our finding that PAXX/XLF-deficient pro-B cells have
increased sensitivity to radiation-induced DNA damage than
XRCC4-deficient pro-B cells. This result is reminiscent of the
observation that XRCC4/XLF-deficient cells are more sensitive
to hydroxyurea and zeocin than XRCC4-deficient cells (Roy
et al., 2015). Considering that XLF function in stabilizing and
joining DNA ends depends on XRCC4, these data indicate that
XLF also plays XRCC4-independent function(s) during DSB
repair.
The question remains of how PAXX rejoins RAG-cleaved DNA
ends and whether this function is regulated. In response to gen-
otoxic stress, ATM phosphorylates hundreds of proteins active
in different aspects of the DNA damage response (Matsuoka
et al., 2007). It will be interesting to test whether ATM regulates,
possibly through phosphorylation, PAXX in response to RAG
cleavage. This would potentially explain the severe end-joining
defect observed in ATM/XLF cells (Kumar et al., 2014; ZhaCell Reports 16, 2967–2979, September 13, 2016 2975
Figure 7. A Lock-and-Join Model for Repair of DNA Ends During V(D)J Recombination
During V(D)J recombination, coding ends stay associatedwith the RAGproteins in a post-cleavage complex (RAG-PCC). Together with the ATM-dependent DNA
damage response (ATM-DDR), the RAG-PCC contributes to stabilization (locking) of broken DNA ends. In the absence of RAG or ATM-DDR, XLF, most likely
through the formation of XLF-XRCC4 hetero-filaments ensure tethering of DNA ends and the formation of CJs. Unlike its paralog XLF, PAXX does not seem to play
major roles in locking broken coding ends. Instead, PAXX contributes to their joining, possibly by promoting the stimulation of the XRCC4/Ligase 4 enzymatic
complex. This end-joining function is redundant with XLF and requires interaction with Ku.
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et al., 2011). XLF has been proposed to stimulate DSB ligation by
promoting the adenylation of XRCC4/Ligase 4 (Riballo et al.,
2009), and, in the absence of XLF, PAXX could potentially act
as substitute for XLF in stimulating Ligase 4. Indeed, in vitro,
both PAXX and XLF have been reported to stimulate XRCC4/
Ligase 4-mediated end joining at certain types of DNA ends
(Ochi et al., 2015; Xing et al., 2015).Morework is needed to parse
whether PAXX participates in joining DNA ends by directly stim-
ulating Ligase 4 catalysis, promoting the assembly of core NHEJ
factors to chromatin (Ochi et al., 2015), and/or promoting a yet
undescribed mechanism.
Genetic mouse models and human patients with hereditary
defects in NHEJ factors suffer from a large variety of defects,
including radiation sensitivity, immunodeficiency, develop-
mental defects, and predisposition to cancer (Revy et al.,
2005; Rooney et al., 2004). It will be interesting to see whether
Paxx knockout and Paxx/Xlf double knockout animals harbor
such developmental and immunological defects and to what
extent.EXPERIMENTAL PROCEDURES
CRISPR/Cas9 Gene Knockout in pro-B Cells
Please refer to Table S1 for a complete list of v-abl pro-B cell lines used in this
study. All animal experiments were performed in accordance with the guide-
lines of the institutional animal care committee of Institut Pasteur/CEEA
Ile-de-France-Paris1 under the protocol no. 2012-0036.
Generation of Paxx/ pro-B Cell Lines
v-abl pro-B cell lines were cultured in RPMI/15%FBS/Pen-Strep as previously
reported (Lescale et al., 2016). Small-guide RNAs (sgRNAs) were designed
with CRISPR DESIGN online tool (Zhang lab) and cloned into a MLM3636 vec-
tor. sgRNA-P1: 50-CAGCAGGGCGGTCTCGCCGC-30, sgRNA-P2: 50-ATGCA
ACCTAGAGAGGCGGC-30, and sgRNA-P3: 50-ACTAGAGGTTGAAGTCGT
CG-30. Two strategies were set up to inactivate Paxx gene. The first one
deleted all of exons 1–4 (sgRNA-P1 + sgRNA-P2), removing the ATG start
codon. The second strategy (sgRNA-P2 + sgRNA-P3) deleted part of exons
1–4, contributing to b sheets 3–7 and a helixes 1–3 (Xing et al., 2015) and
led to frameshift and/or stop mutations 30 of sgRNA-P2 in all clones used in
this study (Figure 1 and Table S1). 15million pro-B cells were transfected using
the Cell Line Nucleofector Kit V from Lonza (program X-001, Amaxa
Nucleofector Technology) and 10 mg of plasmid. Electroporated cells
were resuspended in regular RPMI/FBS/Pen-Strep medium at a density of
1 3 106 cells/ml. After 24–48 hr recovery, cells were isolated in 96-well plates
by single-cell sorting with an ARIA II (BD Biosciences). After 1 week, clones
were screened by PCR using primers 50-ATGAGAGACTCCCCTGGACA 30
and 50-ACCCGGAAACAATGTCAACC-30 amplifying around the expected
deletion site. The absence of the protein was confirmed by western blot (see
Figure 1).
Generation of Paxx/ Atm/ pro-B cell Lines
Paxx/Atm/ pro-B cell cloneswere generated by deleting Paxx from estab-
lished Atm/ pro-B cell lines as described previously.
Generation of Paxx/ Rag2c/c pro-B Cell Lines
Paxx/ Rag2c/c pro-B cell clones were generated by deleting Paxx from
established Rag2c/c pro-B cell lines as described previously.
Generation of Xlf/ and Paxx/ Xlf/ pro-B Cell Lines
Xlf/ and Paxx/ Xlf/ pro-B cell cloneswere generated by deleting Xlf exon
1 from WT and Paxx/ pro-B cells, respectively, using sgRNA-X1: 50-TTAG
CATACACCAACTTC-30 and sgRNA-X2: 50-CACCAACAGGTACTCATA-30.
Clones were screened by PCR using primers 50-ACAAGGTCTAATGC
ACCCCA-30 and 50-GGGTTGCAGCCTTAGAAAAGT-30.
Generation of Xrcc4/ pro-B Cell Lines
Xrcc4/ pro-B cell clones were generated by deleting part of Xrcc4 exon 3
from WT pro-B cells using sgRNA-Xr1: 50-GAATGTATAACAGGAGACGG-30and sgRNA-Xr2: 50-GCCGAGACTCCTTAGAAAAG-30. Clones were screened
by PCR using primers 50-CCCTCACAGAAACACAACTCA-30 and 50-CAAG
GAGGTGGCCACTAGTT-30.
Irradiation Sensitivity Assay
Pro-B cells were plated in 12-well plates at 0.53 106 cells/ml. Cells were irra-
diated at 0, 1, 2.5, or 5 Gy (Faxitron X-ray). 3 days after irradiation, viable cells
were counted with a Casy cell counter (Roche). The percentages of viable cells
compared to non-irradiated control cells were determined. Experiments were
performed using two independent cell lines of each genotype and were
repeated three times (see Table S2).
Western Blotting
Cells were lysed using RIPA cell lysis reagent (Thermo Fisher Scientific) and
protease inhibitors cocktail (Sigma-Aldrich). Equal amountsofproteinswere sub-
jected to SDS-PAGE on 4%–12%Bis-Tris gel. Proteins were transferred onto a
nitrocellulose membrane (Life Technologies) using the iBlot apparatus (P3
program, 7 min transfer, Invitrogen). The membrane was exposed to Ponceau
red staining (Sigma-Aldrich), washed, incubated in 5% non-fat dried milk in
TBS containing 0.05% Tween-20 buffer for 1 hr at room temperature (RT), and
subsequently incubated overnight at 4C with primary antibody against PAXX
protein (ab126353, 1:1000 dilution, Abcam) and g-Tubulin protein (T6557,
1:20,000 dilution, Sigma-Aldrich). The membrane was then washed three times
with TBS-Tweenbefore incubation for 1hratRTwithHRP-conjugatedantibodies
(7,074 or 7,076, 1:20,000 dilution, Cell Signaling Technology). Immune com-
plexes were detected with WesternBright Sirius substrate (Advansta).
V(D)J Recombination Assays
The pMX-INV, pMX-DELCJ, or pMX-DELSJ substrates were introduced in pro-
B cell lines through retroviral infection, and cells that had integrated the recom-
bination substrate were enriched based on hCD4 expression (Bredemeyer
et al., 2006; Liang et al., 2002). For V(D)J recombination assay, v-abl-trans-
formed, Bcl2/pMX-INV-infected pro-B cells (106/ml) were treated with 3 mM
of the v-abl kinase inhibitor STI571 (referred to as ABLki in this study, Novartis)
and assayed for rearrangement by FACS analysis of GFP expression or
Southern blotting at 0, 72, and/or 96 hr. In some experiments, the ATM kinase
inhibitor KU55933 was added at 15 mM together with STI571. For FACS
analysis, V(D)J recombination efficiency was scored as the percentage of
GFP-positive cells among hCD4-positive cells (human CD4-PE, Miltenyi
Biotec, 1:20 dilution). The pMX-INV-mCherry substrate was built by replacing
the inverted GFP cDNA from pMX-RSS-GFP/IRES-hCD4 (pMX-INV) by an in-
verted mCherry cDNA.
Southern Blot
Southern blots were performed as previously described (Lescale et al., 2016).
50 mg of gDNA from untreated, ABLki-treated and ABLki/ATMki-treated pro-B
cell lines were digested overnight with EcoRV for both pMX-DELCJ and pMX-
DELSJ and with EcoRV or EcoRV/NcoI for pMX-INV. Digested gDNA samples
were run overnight on an agarose gel, denatured by incubating the gel with
0.5 M NaOH/0.6M NaCl for 1 hr, and then transferred overnight on a Zeta-
Probe GT nylon membrane (BioRad). DNA was cross-linked on the membrane
using a UV Cross-linker CL-508 (Uvitec Cambridge). Blots were incubated at
42C in pre-hybridization buffer for at least 1 hr and then overnight in hybridi-
zation buffer containing 32P-CTP-labeled C4 probe (Bredemeyer et al., 2006).
Blots were washed in 2XSSC/0.1% SDS at 65C and exposed to a Storage
Phosphor Screen (GE Healthcare) for 2 to 5 days. The screen was then
scanned using a Storm 860 PhosphoImager (Molecular Dynamics).
PCR Analysis of V(D)J Recombination Products
pMX-DELCJ CJs, pMX-DELSJ SJs, and pMX-INV HJs were amplified using pC
(GCACGAAGTCTTGAGACCT) and IRES-REV5 (CTCGACTAAACACATG
TAAAGC) oligonucleotides. pMX-INV CJs were amplified using pA (CACAA
CATCGAGGACGG) and IRES-REV5 primers as previously described (Brede-
meyer et al., 2006; Helmink et al., 2011). Il-2 gene was amplified using
IMR42 (CTAGGCCACAGAATTGAAAGATCT) and IMR43 (GTAGGTG
GAAATTCTAGCATGATGC) primers and was used as loading control. pMX-
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(New England Biolabs) for 2 hr at 37C. pMX-DELSJ SJs were cloned using
TOPO TA Cloning kit (Life Technologies) following the manufacturer’s instruc-
tions and analyzed with Sanger Sequencing using T3 (AATTAACCCTCAC
TAAAGGGA) and T7 (TAATACGACTCACTATAGG) primers.
Endogenous Vk6-23/Jk1 coding and HJs were amplified as previously
described (Bredemeyer et al., 2006). 500 ng of genomic DNA was amplified
using pkJa (GGAGAGTGCCAGAATCTGGTTTCAG) and pk6a (TGCATGTCA
GAGGGCACAACTG) primers for HJ and pkJa2 (GCCACAGACATAGA
CAACGGAA) and pk6d (GAAATACATCAGACCAGCATGG) primers for CJ.
Serial 4-fold dilutions of this reaction were amplified using pkJa and pk6b
(CTACCAAACTTTGCAACACACAGGC) primers for HJ and pkJa2 and pk6c
(GTTGCTGTGGTTGTCTGGTG) primers for CJ.
Immunofluorescence on Interphase Nuclei
After 3 days of treatment with ABLki, pro-B cell lines were adhered to poly-L
lysine-coated coverslips and stained as previously described (Chaumeil
et al., 2013; Lescale et al., 2016). Cells were fixed with 4% paraformalde-
hyde/PBS for 10 min at RT and permeabilized for 5 min with 0.4% Triton/
PBS on ice. Immunofluorescence was performed after 30 min blocking in
2.5% BSA/10% goat serum/0.1% Tween-20/PBS, with a primary antibody
against 53BP1 (NB100-304SS, 1:600 dilution, Novus Biologicals) and a
secondary goat-anti-rabbit antibody (Alexa Fluor 594, 1:900 dilution; Life
Technologies) in blocking solution for 1 hr each at RT. Cells were washed three
times with 0.5% BSA/0.1% Tween-20/PBS after both primary and secondary
antibody incubations. Finally, slides weremounted in ProLongGold (Life Tech-
nologies) containing DAPI) to counterstain total DNA. Cells were imaged in 3D
(nine z stacks of 0.5 mm) using a Zeiss AxioImager Z2 microscope and the
Metacyte automated capture system (Metasystems). 53BP1 foci were
counted using a custom Metacyte classifier. >10,000 nuclei were counted
for each genotype (see Table S3).
PAXX Expression Vectors
Plasmids encoding for GFP-tagged PAXX have been described previously
(Ochi et al., 2015). DNA encoding mRuby2-tagged PAXX was synthesized
and cloned into pcDNA3.1/Zeo(+) vector (Life Technologies). S184E mutation
was introduced by site-directedmutagenesis (Agilent Technologies). Plasmids
were transfected into 293FT cells using Lipofectamine 2000 (Life Technolo-
gies) for subsequent immunoprecipitation experiments.
Immunoprecipitation
GFP pull-downs were carried out in 293FT cells exactly as previously
described (Blackford et al., 2015). Antibody recognizing Ku80 (MS-285-P1,
Thermo Scientific) was diluted 1:2,000 for western blotting experiments.
PAXX Complementation of v-abl pro-B Cells
pMX-INV-GFP/mCherry pro-B cells were transfected with plasmids encoding
for PAXX and mutated PAXX using the Cell Line Nucleofector Kit V from Lonza
using the same conditions as for the previously described CRISPR/Cas9
gene knockout strategy. Cells were left to recover in fresh media for 6 hr and
subsequently treated with ABLki and assayed for V(D)J recombination by
FACS analysis as previously described.
Statistics
All statistical analyses were performed using a non-parametric Mann-Whitney
test. In all statistical tests, p < 0.05 were taken to be significant (*, 0.01 %
p < 0.05; **, 0.001% p < 0.01; ***, p < 0.001).
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